Copyright
©The Author(s) 2020.
World J Gastroenterol. Oct 7, 2020; 26(37): 5561-5596
Published online Oct 7, 2020. doi: 10.3748/wjg.v26.i37.5561
Published online Oct 7, 2020. doi: 10.3748/wjg.v26.i37.5561
Ref. | No. of pts (TIPS/control) | Primary inclusion criteria | Primary and secondary end-points | Rebleeding (%; TIPS/control) | 1-yr survival (%; TIPS/control) | HE (%; TIPS/control) |
Monescillo et al[13] | 26/26 | HVPG > 20 mmHg | Primary: sensivity and specificity of HVPG cutoff value (20 mmHg) in predicting TFS, and assessment of TFS as well as short- and long-term survival; secondary: transfusional needs, ICU stay, complications during the first week of treatment, and causes of death | 12/50 | 62/35 | 31/35 |
Garcia-Pagán et al[14] | 32/31 | Child–Pugh class C disease (a score of 10 to 13) or class B disease but with active bleeding at diagnostic endoscopy | Primary: failure to control bleeding and failure to prevent clinically significant variceal rebleeding within 1 yr; secondary: mortality at 6 wk and at 1 yr, failure to control acute bleeding, early rebleeding, rate of rebleeding between 6 wk and 1 yr, other complications of portal hypertension, the number of days in the ICU, days spent in the hospital, and the use of alternative treatments | 3/50 | 86/61 | 25/39 |
Lv et al[20] | 84/45 | Child–Pugh class C disease (a score of 10 to 13) or class B disease (with or without active bleeding at diagnostic endoscopy) | Primary: TFS; secondary: failure to control bleeding or rebleeding, new or worsening ascites, overt HE, and other complications of portal hypertension | 11/34 | 62/35 | 35/36 |
Dunne et al[21] | 29/29 | Child–Pugh class C disease (a score of 10 to 13) or class B disease (with or without active bleeding at diagnostic endoscopy); inability to control bleeding at index endoscopy was considered an exclusion criteria | Primary: 1-yr survival; secondary: survival at 6 wk, early rebleeding (within 6 wk) and late rebleeding (between 6 wk and 1 yr), and the development of HE | 24/34 | 79/76 | 41/17 |
- Citation: Rajesh S, George T, Philips CA, Ahamed R, Kumbar S, Mohan N, Mohanan M, Augustine P. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update. World J Gastroenterol 2020; 26(37): 5561-5596
- URL: https://www.wjgnet.com/1007-9327/full/v26/i37/5561.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i37.5561